Kaliumphosphat B. Braun

Dipotassium phosphate, the active ingredient in Kaliumphosphat B. Braun, is an electrolyte supplement presented as an injectable solution for intravenous use. It is employed to correct potassium and phosphate deficiencies and to support cellular metabolism in patients with electrolyte disturbances.

GNH USA supplies Kaliumphosphat B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, providing regulated sourcing, quality assurance, and logistics for healthcare institutions across global markets.

Kaliumphosphat B. Braun is used to replenish electrolytes in conditions affecting phosphate and potassium balance.

- Hypophosphatemia: restores serum phosphate concentrations to normal levels. - Hypokalemia: supplies potassium ions to raise low serum potassium. - Peri‑operative electrolyte replacement: provides rapid correction of electrolyte deficits during surgery. - Acid‑base disorders: assists in correcting metabolic imbalances associated with phosphate and potassium shifts.

Intravenous administration of Kaliumphosphat B. Braun may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema. - Mild hyperphosphatemia. - Transient hypotension.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmias. - Metabolic alkalosis. - Calcium‑phosphate precipitation causing tissue injury. - Anaphylactic reaction.

Prior to using Kaliumphosphat B. Braun, clinicians should observe several safety considerations.

- Monitor serum electrolytes: check potassium and phosphate levels before and during infusion. - Assess renal function: impaired kidneys may reduce clearance of phosphate and potassium. - Avoid rapid infusion: administer over recommended time to prevent cardiovascular effects. - Use cautiously in cardiac disease: high potassium can exacerbate arrhythmias. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kaliumphosphat B. Braun can interact with other medications that affect electrolyte balance.

Major Interactions (Avoid): - Concurrent potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Co‑administration with calcium‑containing solutions: risk of calcium‑phosphate precipitation. - Use with other phosphate salts: can lead to severe hyperphosphatemia.

Moderate Interactions (Monitor Closely): - Intravenous bicarbonate therapy: may alter acid‑base status when combined. - Loop diuretics: increase renal potassium loss, requiring electrolyte monitoring. - ACE inhibitors or ARBs: can potentiate potassium elevation.